Results 181 to 190 of about 3,388,275 (347)

Creating an interventional oncology translational database: early experience at Indiana University [PDF]

, 2016
Judy Wawira Gichoya, Paul Haste, Alexandra Mills, Mark D. Kohli, Matthew S. Johnson   +4 more
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Supplementary Material for: Peri-procedural Oral Hydration Patterns and Early Renal Function after Coronary Angiography and Intervention: A Prospective Real-world Cohort Study

figshare admin karger, Zhu D., Gao L., Zhuang N., Ma Y., Fan L., Ma H., Zheng Y.   +7 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Neurodevelopmental outcome at 5 to 6 years of age of an early intervention program in preterm infants. [PDF]

Sci Rep
Fontana C, Provitera L, Bonfanti C, Schiavolin P, Polimeni B, Marasca F, Pesenti N, Iuliano R, Gangi S, Bodega B, Fumagalli M.   +10 more
europepmc   +1 more source

A 25-year long-term implementation review of an early intervention for psychosis programme in Hong Kong (part 1): planning and initial development

Eric YH. Chen, SF Hung, S F So, Dicky WS Chung, Steve Tso, CW Wong, May M.L. Lam, Su Chan, W.C. Chang, Christy LM Hui, Eric Yan, Frendi Li, Amy KWY Chan, Joy Kok   +13 more
openalex   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Duration of untreated illness in psychosis: conceptualising duration of the psychosis prodrome and duration of untreated psychosis in predicting outcome and refining early intervention

John L. Waddington, Nnamdi Nkire, Anthony Kinsella, Vincent Russell, Mary Clarke   +4 more
openalex   +1 more source

Early discharge of patients (within 24 h) after percutaneous coronary intervention is feasible and safe in Indian setup

, 2020
Refai Showkathali, Radhapriya Yalamanchi, Abraham Oomman   +2 more
openalex   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source